Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis

References

• Adriano B, Cotto NM, Chauhan N, et al. (2021). Milk exosomes: nature's abundant nanoplatform for theranostic applications. Bioact Mater 6:2479–90.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, et al. (2015). Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005.
   PubMed Web of Science ®Google Scholar
• Agrawal AK, Aqil F, Jeyabalan J, et al. (2017). Milk-derived exosomes for oral delivery of paclitaxel. Nanomedicine 13:1627–36.
   PubMed Web of Science ®Google Scholar
• Al-Kafaji G, Al-Mahroos G, Al-Muhtaresh HA, et al. (2016). Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: a potential blood-based biomarker. Exp Ther Med 12:815–22.
   PubMed Web of Science ®Google Scholar
• Ambros V. (2001). MicroRNAs: tiny regulators with great potential. Cell 107:823–6.
   PubMed Web of Science ®Google Scholar
• Aqil F, Kausar H, Agrawal AK, et al. (2016). Exosomal formulation enhances therapeutic response of celastrol against lung cancer. Exp Mol Pathol 101:12–21.
   PubMed Web of Science ®Google Scholar
• Aqil F, Munagala R, Jeyabalan J, et al. (2019). Milk exosomes – natural nanoparticles for siRNA delivery. Cancer Lett 449:186–95.
   PubMed Web of Science ®Google Scholar
• Arntz OJ, Pieters BCH, Oliveira MC, et al. (2015). Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models. Mol Nutr Food Res 59:1701–12.
   PubMed Web of Science ®Google Scholar
• Ben-Shushan D, Markovsky E, Gibori H, et al. (2014). Overcoming obstacles in microRNA delivery towards improved cancer therapy. Drug Deliv Transl Res 4:38–49.
   PubMed Web of Science ®Google Scholar
• Betker JL, Angle BM, Graner MW, et al. (2019). The potential of exosomes from cow milk for oral delivery. J Pharm Sci 108:1496–505.
   PubMed Web of Science ®Google Scholar
• Boca S, Gulei D, Zimta A, et al. (2020). Nanoscale delivery systems for microRNAs in cancer therapy. Cell Mol Life Sci 77:1059–86.
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, et al. (2005). The global burden of diabetic foot disease. Lancet 366:1719–24.
   PubMed Web of Science ®Google Scholar
• Carobolante G, Mantaj J, Ferrari E, et al. (2020). Cow milk and intestinal epithelial cell-derived extracellular vesicles as systems for enhancing oral drug delivery. Pharmaceutics 12:226.
   PubMed Web of Science ®Google Scholar
• Chen Y, Gorski DH. (2008). Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111:1217–26. 2008-02-01
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang X. (2020). miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48:D127–31.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang Q, Liu D, et al. (2021). Exosomes: advances, development and potential therapeutic strategies in diabetic nephropathy. Metabolism 122:154834.
   PubMed Web of Science ®Google Scholar
• Cheung CC, Chung GT, Lun SW, et al. (2014). MiR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis. Mol Cancer 13:184.
   PubMed Web of Science ®Google Scholar
• Chiba T, Cerqueira DM, Li Y, et al. (2021). Endothelial-derived miR-17 ∼ 92 promotes angiogenesis to protect against renal ischemia-reperfusion injury. J Am Soc Nephrol 32:553–62.
   PubMed Web of Science ®Google Scholar
• Chouhan D, Dey N, Bhardwaj N, et al. (2019). Emerging and innovative approaches for wound healing and skin regeneration: current status and advances. Biomaterials 216:119267.
   PubMed Web of Science ®Google Scholar
• Davis FM, Kimball A, Boniakowski A, et al. (2018). Dysfunctional wound healing in diabetic foot ulcers: new crossroads. Curr Diab Rep 18:2.
   PubMed Web of Science ®Google Scholar
• Del Pozo-Acebo L, López De Las Hazas M, Tomé-Carneiro J, et al. (2021). Bovine milk-derived exosomes as a drug delivery vehicle for miRNA-based therapy. IJMS 22:1105.
   Web of Science ®Google Scholar
• EL Andaloussi S, Mäger I, Breakefield XO, et al. (2013). Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347–57.
   PubMed Web of Science ®Google Scholar
• Faruqu FN, Xu L, Al-Jamal KT. (2018). Preparation of exosomes for siRNA delivery to cancer cells. J Vis Exp 142:10.3791/58814..
   Google Scholar
• Feng L, Mumper RJ. (2013). A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett 334:157–75.
   PubMed Web of Science ®Google Scholar
• Grennan D. (2019). Diabetic foot ulcers. JAMA 321:114.
   PubMedGoogle Scholar
• Grossen P, Portmann M, Koller E, et al. (2021). Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides. Eur J Pharm Biopharm 158:198–210.
   PubMedGoogle Scholar
• Ha D, Yang N, Nadithe V. (2016). Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B 6:287–96.
   PubMed Web of Science ®Google Scholar
• Herrmann IK, Wood MJA, Fuhrmann G. (2021). Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol 16:748–59.
   PubMed Web of Science ®Google Scholar
• Hong WX, Hu MS, Esquivel M, et al. (2014). The role of hypoxia-inducible factor in wound healing. Adv Wound Care 3:390–9.
   Google Scholar
• Hu J, Chen C, Liu Q, et al. (2015). The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis. Clin Sci 129:305–17.
   Web of Science ®Google Scholar
• Huang M, Nguyen P, Jia F, et al. (2011). Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation 124:S46–S54.
   PubMed Web of Science ®Google Scholar
• Jeong K, Yu YJ, You JY, et al. (2020). Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model. Lab Chip 20:548–57.
   PubMed Web of Science ®Google Scholar
• Jiao X, Sherman BT, Huang da W, et al. (2012). DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics 28:1805–6.
   PubMed Web of Science ®Google Scholar
• Kandimalla R, Aqil F, Alhakeem SS, et al. (2021). Targeted oral delivery of paclitaxel using colostrum-derived exosomes. Cancers 13:3700.
   PubMed Web of Science ®Google Scholar
• Kandimalla R, Aqil F, Tyagi N, et al. (2021). Milk exosomes: a biogenic nanocarrier for small molecules and macromolecules to combat cancer. Am J Reprod Immunol 85:e13349.
   PubMed Web of Science ®Google Scholar
• Kim G, Kim M, Lee Y, et al. (2020). Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J Control Release 317:273–81.
   PubMed Web of Science ®Google Scholar
• Lando D, Peet DJ, Gorman JJ, et al. (2002). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16:1466–71.
   PubMed Web of Science ®Google Scholar
• Li D, Li XI, Wang A, et al. (2015). MicroRNA-31 promotes skin wound healing by enhancing keratinocyte proliferation and migration. J Invest Dermatol 135:1676–85.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. (2014). starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92–7.
   PubMed Web of Science ®Google Scholar
• Liang Y, Duan L, Lu J, et al. (2021). Engineering exosomes for targeted drug delivery. Theranostics 11:3183–95.
   PubMed Web of Science ®Google Scholar
• Liang G, Kan S, Zhu Y, et al. (2018). Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomedicine 13:585–99.
   PubMed Web of Science ®Google Scholar
• Liang G, Zhu Y, Ali DJ, et al. (2020). Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnology 18:10.
   PubMed Web of Science ®Google Scholar
• Lim E, Jang E, Lee K, et al. (2013). Delivery of cancer therapeutics using nanotechnology. Pharmaceutics 5:294–317.
   PubMedGoogle Scholar
• Liu Y, Ding M, Liu D, et al. (2015). MicroRNA profiling in cutaneous wounds of diabetic rats. Genet Mol Res 14:9614–25.
   PubMed Web of Science ®Google Scholar
• Liu S, Sun Z, Zhou D, et al. (2017). Alkylated branched poly(β-amino esters) demonstrate strong DNA encapsulation, high nanoparticle stability and robust gene transfection efficacy. J Mater Chem B 5:5307–10.
   PubMed Web of Science ®Google Scholar
• Liu C, Tsai M, Hung P, et al. (2010). MiR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 70:1635–44.
   PubMed Web of Science ®Google Scholar
• Luan X, Sansanaphongpricha K, Myers I, et al. (2017). Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38:754–63.
   PubMed Web of Science ®Google Scholar
• Luo S, Sun X, Huang M, et al. (2021). Enhanced neuroprotective effects of epicatechin gallate encapsulated by bovine milk-derived exosomes against Parkinson's disease through antiapoptosis and antimitophagy. J Agric Food Chem 69:5134–43.
   PubMed Web of Science ®Google Scholar
• Ma T, Chen Y, Chen Y, et al. (2018). MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction. Stem Cells Int 2018:3290372.
   PubMed Web of Science ®Google Scholar
• Mahon PC, Hirota K, Semenza GL. (2001). FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15:2675–86.
   PubMed Web of Science ®Google Scholar
• Matsuda A, Moirangthem A, Angom RS, et al. (2020). Safety of bovine milk derived extracellular vesicles used for delivery of RNA therapeutics in zebrafish and mice. J Appl Toxicol 40:706–18.
   PubMed Web of Science ®Google Scholar
• Meng S, Cao J, Zhang X, et al. (2013). Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One 8:e68611.
   PubMed Web of Science ®Google Scholar
• Meng Z, Zhou D, Gao Y, et al. (2018). MiRNA delivery for skin wound healing. Adv Drug Deliv Rev 129:308–18.
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Jeyabalan J, et al. (2016). Bovine milk-derived exosomes for drug delivery. Cancer Lett 371:48–61.
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Jeyabalan J, et al. (2017). Exosomal formulation of anthocyanidins against multiple cancer types. Cancer Lett 393:94–102.
   PubMed Web of Science ®Google Scholar
• Nie X, Zhao J, Ling H, et al. (2020). Exploring microRNAs in diabetic chronic cutaneous ulcers: Regulatory mechanisms and therapeutic potential. Br J Pharmacol 177:4077–95.
   PubMed Web of Science ®Google Scholar
• Ohtsuka M, Iwamoto K, Naito A, et al. (2021). Circulating microRNAs in gastrointestinal cancer. Cancers 13:3348.
   PubMed Web of Science ®Google Scholar
• Peng H, Kaplan N, Hamanaka RB, et al. (2012). MicroRNA-31/factor-inhibiting hypoxia-inducible factor 1 nexus regulates keratinocyte differentiation. Proc Natl Acad Sci USA 109:14030–4.
   PubMed Web of Science ®Google Scholar
• Petkovic M, Sørensen AE, Leal EC, et al. (2020). Mechanistic actions of microRNAs in diabetic wound healing. Cells 9:2228.
   PubMed Web of Science ®Google Scholar
• Pirisinu M, Pham TC, Zhang DX, et al. (2020). Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: recent advances, current obstacles, and challenges for clinical translation. Semin Cancer Biol.
   PubMed Web of Science ®Google Scholar
• Plantz PE, Patton S, Keenan TW. (1973). Further evidence of plasma membrane material in skim milk. J Dairy Sci 56:978–83. 1973-01-01
   PubMed Web of Science ®Google Scholar
• Rani S, Ritter T. (2016). The exosome – a naturally secreted nanoparticle and its application to wound healing. Adv Mater 28:5542–52.
   PubMed Web of Science ®Google Scholar
• Rani P, Vashisht M, Golla N, et al. (2017). Milk miRNAs encapsulated in exosomes are stable to human digestion and permeable to intestinal barrier in vitro. J Funct Foods 34:431–9.
   Web of Science ®Google Scholar
• Rawal S, Munasinghe PE, Shindikar A, et al. (2017). Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy. Cardiovasc Res 113:90–101.
   PubMed Web of Science ®Google Scholar
• Rey S, Semenza GL. (2010). Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86:236–42.
   PubMed Web of Science ®Google Scholar
• Rodrigues M, Kosaric N, Bonham CA, et al. (2019). Wound healing: a cellular perspective. Physiol Rev 99:665–706.
   PubMed Web of Science ®Google Scholar
• Rovira-Llopis S, Escribano-Lopez I, Diaz-Morales N, et al. (2018). Downregulation of miR-31 in diabetic nephropathy and its relationship with inflammation. Cell Physiol Biochem 50:1005–14.
   PubMedGoogle Scholar
• Sadasivam M, Avci P, Gupta GK, et al. (2013). Self-assembled liposomal nanoparticles in photodynamic therapy. Eur J Nanomed 5(3):10.1515/ejnm-2013-0010.
   PubMedGoogle Scholar
• Sedykh S, Kuleshova A, Nevinsky G. (2020). Milk exosomes: perspective agents for anticancer drug delivery. IJMS 21:6646.
   Web of Science ®Google Scholar
• Sheng H, Hassanali S, Nugent C, et al. (2011). Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice. J Immunol 187:1591–600.
   PubMed Web of Science ®Google Scholar
• Shi J, Ma X, Su Y, et al. (2018). MiR-31 mediates inflammatory signaling to promote re-epithelialization during skin wound healing. J Invest Dermatol 138:2253–63.
   PubMed Web of Science ®Google Scholar
• Smyth T, Kullberg M, Malik N, et al. (2015). Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release 199:145–55.
   PubMed Web of Science ®Google Scholar
• Sorop A, Constantinescu D, Cojocaru F, et al. (2021). Exosomal microRNAs as biomarkers and therapeutic targets for hepatocellular carcinoma. Int J Mol Sci 22:4997.
   PubMed Web of Science ®Google Scholar
• Suárez Y, Wang C, Manes TD, et al. (2010). Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol 184:21–5.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhang Y, Chen Y, et al. (2015). The role of miR-19b in the inhibition of endothelial cell apoptosis and its relationship with coronary artery disease. Sci Rep 5:15132.
   PubMed Web of Science ®Google Scholar
• Tao S, Guo S, Li M, et al. (2017). Chitosan wound dressings incorporating exosomes derived from microRNA-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model. Stem Cells Transl Med 6:736–47.
   PubMed Web of Science ®Google Scholar
• Tao H, Xu H, Zuo L, et al. (2020). Exosomes-coated bcl-2 siRNA inhibits the growth of digestive system tumors both in vitro and in vivo. Int J Biol Macromol 161:470–80.
   PubMed Web of Science ®Google Scholar
• Ullah M, Kodam SP, Mu Q, Akbar A. (2021). Microbubbles versus extracellular vesicles as therapeutic cargo for targeting drug delivery. ACS Nano 15:3612–20.
   PubMed Web of Science ®Google Scholar
• Umezu T, Tadokoro H, Azuma K, et al. (2014). Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood 124:3748–57.
   PubMed Web of Science ®Google Scholar
• Wang H, Huang T, Lo H, et al. (2014). Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease. Arterioscler Thromb Vasc Biol 34:857–69.
   PubMed Web of Science ®Google Scholar
• Wang J, Tao J, Chen D, et al. (2014). MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 34:99–109.
   PubMed Web of Science ®Google Scholar
• Wong HA, Fatimy RE, Onodera C, et al. (2015). The cancer genome atlas analysis predicts microRNA for targeting cancer growth and vascularization in glioblastoma. Mol Ther 23:1234–47.
   PubMed Web of Science ®Google Scholar
• Wu Y, Hu T, Chen Y, et al. (2011). The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood 118:2896–905.
   PubMed Web of Science ®Google Scholar
• Yang P, Cai L, Zhang G, et al. (2017). The role of the miR-17-92 cluster in neurogenesis and angiogenesis in the central nervous system of adults. J Neurosci Res 95:1574–81.
   PubMed Web of Science ®Google Scholar
• Yang Y, Guo Z, Chen W, et al. (2021). M2 macrophage-derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2. Mol Ther 29:1226–38.
   PubMed Web of Science ®Google Scholar
• Yang F, Wang W, Zhou C, et al. (2015). MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2. Tumour Biol 36:3763–73.
   PubMedGoogle Scholar
• Yao X, Lyu P, Yoo K, et al. (2021). Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing. J Extracell Vesicles 10:e12076.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Li Y, Pan Y, et al. (2018). Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun 9:5395.
   PubMed Web of Science ®Google Scholar
• Zgheib C, Hilton SA, Dewberry LC, et al. (2019). Use of cerium oxide nanoparticles conjugated with microRNA-146a to correct the diabetic wound healing impairment. J Am Coll Surg 228:107–15.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cai W, Fan Z, et al. (2019). MicroRNA-24 inhibits the oxidative stress induced by vascular injury by activating the Nrf2/Ho-1 signaling pathway. Atherosclerosis 290:9–18.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun X, Icli B, et al. (2017). Emerging roles for microRNAs in diabetic microvascular disease: novel targets for therapy. Endocr Rev 38:145–68.
   PubMed Web of Science ®Google Scholar
• Zheng D, Huo M, Li B, et al. (2020). The role of exosomes and exosomal microRNA in cardiovascular disease. Front Cell Dev Biol 8:616161.
   PubMed Web of Science ®Google Scholar
• Zhou D, Cutlar L, Gao Y, et al. (2016). The transition from linear to highly branched poly (β-amino ester)s: branching matters for gene delivery. Sci Adv 2:e1600102.
   PubMed Web of Science ®Google Scholar
• Zhu B, Cao X, Zhang W, et al. (2019). MicroRNA-31-5p enhances the Warburg effect via targeting FIH. FASEB J 33:545–56.
   PubMed Web of Science ®Google Scholar
• Zubair M, Ahmad J. (2019). Role of growth factors and cytokines in diabetic foot ulcer healing: a detailed review. Rev Endocr Metab Disord 20:207–17.
   PubMed Web of Science ®Google Scholar